FDA delays review of Pfizer shot for kids under 5

The FDA announced Friday that it will delay a long-awaited review of Pfizer's two-shot vaccine protocol for children as young as 6 months old and says it will wait for more data.

February 11, 2022

Top Stories

ABC News Live Presents